ArticleProceedings of the National Academy of Sciences of the United States of America2014

Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis.

Anna Ridderstad Wollberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.